Table 2 Estimated mean annual number of new HPV-attributable cancer cases in women and men in Europe
Cancer site | New cancers N, (95% bound) | New cancers attributable to all HPV types N, (95% bound)a | New cancers attributable to 9-valent HPV vaccine types (6/11/16/18/31/33/45/52/58) N, (95% bound)a |
|---|---|---|---|
Cervical cancer | 34,939 (32,863 – 37,032) | 34,939 (32,863 – 37,032) | 31,130 (28,800 – 33,495) |
Vulvar cancer | 9,776 (8,727 – 10,841) | 1,554 (1,135 – 2,044) | 1,466 (1,008 – 1,994) |
Vaginal cancer | 2,224 (1,723 – 2,744) | 1,562 (1,058 – 2,134) | 1,360 (827 – 1,980) |
Anal cancer (F) | 4,663 (3,968 – 5,375) | 4,062 (3,203 – 4,940) | 3,834 (2,851 – 4,818) |
Head and neck cancers (F) | 18,052 (13,977 – 22,183) | 1,396 (728 – 2,592) | 1,301 (586 – 2,574) |
Total (women) | 69,654 (61,754 – 77,609) | 43,512 (39,256 – 48,387) | 39,091 (34,320 – 44,513) |
Anal cancer (M): | 2,801 (2,260 – 3,359) | 2,440 (1,822 – 3,088) | 2,303 (1,621 – 3,012) |
Penile cancer | 4,231 (3,543 – 4,937) | 1,227 (845 – 1,697) | 1,113 (707 – 1,619) |
Head and neck cancers (M) | 81,989 (73,563 – 90,469) | 5,834 (3,729 – 9,735) | 5,485 (2,923 – 9,680) |
Total (men) | 89,021 (79,558 – 98,543) | 9,501 (6,502 – 14,376) | 8,901 (5,348 – 14,168) |
Total (both sexes) | 158,675 (141,617 – 175,815) | 53,013 (45,886 – 62,589) | 47,992 (39,785 – 58,511) |